Legionella pneumophila is an important pathogen that may cause nosocomial and communityacquired pneumonia in patients with normal or altered immunity. The epidemiology of 40 cases of legionella pneumonia in patients hospitalized between 1986 and 1994 was studied. Fourteen patients (35%) were solid organ transplant recipients. The calculated annual incidence of L. pneumophila infection was highest among lung transplant recipients (2.07 cases per 1,000 transplant-years). There was a trend toward reduced mortality rates and less severe disease among transplant patients vs. nontransplant patients: mortality rate, 36% vs. 54%; incidence of intubation, 50% vs. 69%; rate of concurrent infections, 29% vs. 38%; and overall rate of complications, 86% vs. 96%; respectively. In a multivariate analysis, factors independently associated with an increased mortality rate were nosocomial acquisition, need for intubation, formation of lung abscess or cavitation, and presence of pleural effusion. Thus, despite differing host immune responses, the most important prognostic factors affecting the outcome of legionellosis are nosocomial acquisition and the development of pulmonary complications.
Since its discovery in 1976, Legionella pneumophila has been
Presbyterian University Hospital, a 600-bed teaching hospital recognized as an important cause of community-and hospitalin Pittsburgh, were identified from review of infection control acquired pneumonia in both healthy and immunosuppressed hosts and microbiology laboratory records. A case was defined as including organ transplant recipients [1, 2] . Legionnaires' disease culture of a specimen from any body fluid or tissue that was has occurred in patients receiving heart, liver, kidney, lung, and positive for Legionella species (39 cases) or direct fluorescent bone marrow transplants [3] [4] [5] [6] [7] . In the nontransplant population, antibody (DFA) staining positive for Legionella species if the legionella remains a significant cause of pneumonia, with an culture had an overgrowth of normal flora (one case). associated mortality rate of 14%-43% [8, 9] . Organ transplantaChart review. All medical records were reviewed for data tion may increase the risk and severity of disease and the mortality collection. For two patients whose medical records were not rate associated with legionellosis, but comparative data are lackavailable for review, information was obtained from the hospiing [2, 10, 11] . The largest series of legionella pneumonia retal's electronic information database MARS (Medical Archival ported in the literature comprises 65 cases, of which only six Retrieval System). Included in this database are the admission were in organ transplant recipients [2] . At our institution, a large history and physical examination results, discharge summary, organ transplantation center, sporadic cases of legionellosis have dictated progress notes, medications dispensed from the pharoccurred in both transplant recipients and other immunocommacy, and all laboratory data. promised as well as immunocompetent hosts. In a historical proDemographic data including race, birth date, sex, dates of spective study, we investigated the epidemiology and outcome admission and discharge, dates of all previous organ transplant of legionella infection in both transplant and nontransplant paoperations, and outcome of present hospitalization were tabutients over an 8-year period.
lated. The admission history and physical examination results were reviewed for the presence or absence of the following
Patients and Methods
symptoms: fever, cough, hemoptysis, chills or rigors, headache, Case definition. All cases of legionella-related infection dyspnea, chest pain, diarrhea, nausea, vomiting, anorexia, and occurring from 1 January 1986 through 30 December 1994 at confusion. In cases of nosocomial acquisition, the progress notes of the week preceding the diagnosis of legionellosis were examined.
Microbiology data recorded included the date, body fluid site, tinued. Only specimens for which legionella culture was specifically requested were processed in this manner. Cultures and results of cultures of all specimens; results of DFA staining; and results of testing with a DNA probe for Legionella species.
were incubated in a humidified atmosphere at 35ЊC and were examined daily for 5 days by using a dissecting microscope The cause of death was recorded from the discharge summary, death certificate, or autopsy report.
to identify colonies resembling Legionella species. Suspicious colonies were gram-stained and subcultured to plates with Definitions. Date of diagnosis of legionella infection was the date on which a positive DNA probe test or DFA staining sheep blood agar and BCYE agar. DNA probe and/or DFA testing was performed to confirm the presence of L. pneumophwas reported or the date of death if the diagnosis was not established before death. Nosocomial acquisition was defined ila or L. micdadei isolates. Statistical analysis. Differences in means between groups as signs or symptoms of infection occurring ú48 hours after hospital admission. Legionella-related mortality was defined as were tested by using the standard two-sample t test, while differences in proportions were tested by either Pearson's x 2 death that was directly attributed to Legionella species recovered by culture or positive Dieterle's staining of autopsy specitest or Fisher's exact test. The Wilcoxon rank-sum test, a nonparametric equivalent to the standard two-sample t test, was mens of lung tissue [12] or death for which autopsy demonstrated pneumonia along with a premortem culture positive for used for highly skewed data. The approximate average yearly incidence of legionellosis L. pneumophila or Legionella micdadei. In those cases in which an autopsy was not performed, patients whose deaths were and estimates of relative risk for the different transplanted organs were computed by using a multiplicative Poisson regresrespiratory-related within 3 weeks of the diagnosis of legionellosis were considered to have legionella-related mortality.
sion model [13] . The group of liver transplant recipients was used in this analysis as a reference group. The calculations were Concurrent infections were those occurring between 2 weeks before and 4 weeks after the diagnosis of legionellosis was performed by using the statistical program GLIM (Generalized Linear Interactive Modeling) [14] . established. Complications of legionella infection were those that occurred simultaneously with or as a direct result of legioPatient survival was calculated from the date of admission until death. Survival curves were generated by using the nellosis or as an indirect result from management of legionella infection.
Kaplan-Meier product limit method [15] and were compared by the logrank test [16] . Univariate Cox regression [17] was Empyema was defined as culture of pleural fluid positive for L. pneumophila or L. micdadei. Severity of illness was evaluused to identify factors with potential prognostic significance. Variables were included in multivariate Cox regression if they ated by using the following criteria: number of days of hospitalization following diagnosis, incidence of intubation, maximum had a P value of õ.2 at the univariate level or were clinically relevant. The backward elimination method was used to assess temperature, number of concurrent infections, and number of complications (including barotrauma, renal insufficiency or simultaneously the effect of each factor and to identify those factors independently associated with legionella-related mortalfailure, pleural effusion, empyema, or lung abscess or cavitation). Renal insufficiency was defined as either a serum creatiity. The relative risk of mortality and 95% confidence intervals were computed by using Cox regression. Patients who were nine level of ú2.0 mg/dL in patients without known preexisting renal failure or a doubling of the baseline serum creatinine alive at the end of follow-up or who died of causes not attributable to legionellosis were censored. A P value of õ.05 was level within 7 days of the diagnosis of legionellosis for all other patients. considered statistically significant. Microbiology. Before 1 July 1993, all respiratory tract and pulmonary specimens that were submitted to the microbiology Results laboratory for routine culture were inoculated onto buffered charcoal -yeast extract (BCYE) agar containing a-ketoglutaLegionella species were isolated in cultures of specimens from 39 of 40 patients during the study period. Culture of one rate. Culture specimens that were specifically requested for legionella workup were also inoculated onto BCYE agar conpatient's specimen had overgrowth of Pseudomonas aeruginosa. This patient developed a new infiltrate on a chest radiotaining antibiotics (anisomycin, polymyxin B, and cefamandole), but there was no pretreatment of the specimen. Cultures graph 2 days after intubation for respiratory failure. Gram staining of bronchoalveolar lavage fluid showed many WBCs, and that contained ú20 -50 colonies of non-Legionella organisms after 48 hours of incubation were treated with an acid wash DFA staining was positive for L. pneumophila serogroup 1. The number of cases by year according to transplant status and then were replated. DNA screening with use of polyvalent L. pneumophila serogroups 1 -6 and L. micdadei (SciMedex, is shown in figure 1 . In 1992, mechanical failure of the chlorination system of the potable water supply resulted in nine nosocoDenville, NJ) or a DNA probe for Legionella species (GenProbe, San Diego) was performed according to the manufacturmial cases of legionellosis (authors' unpublished data). Control measures included superchlorination of the potable water sysers' protocols.
As of 1 July 1993, the inoculation of all routine sputum tem and consumption of bottled water by patients. Only tub or basin baths were permitted. A second chlorinator was installed culture specimens on legionella-selective media was discon-/ 9c5c$$de38
11-11-98 17:03:57 cida UC: CID institution. The relative risks for lung and heart transplant recipients were 8.60 (95% CI, 1.01 -73.57) and 7.18 (95% CI, 2.19 -23.52), respectively, compared with liver transplant recipients.
Demographics. The legionella-infected population included 40 patients, of whom 14 were organ transplant recipients (table 2) . Fifty-seven percent of the cases in transplant recipients and 54% of the cases in nontransplant recipients were nosocomially acquired. The mean age, the male-to-female ratio, and race distribution were similar between the two groups. The median length of hospitalization before the diagnosis of legionellosis was 7.5 days (range, 2 -105 days) for the transplant group compared with 4 days (range, 0 -34 days) for the nontransplant group (P Å .210). immunosuppressive condition in the nontransplant group was use of corticosteroids (9 cases Legionella species were recovered from the 40 patients. These nation phase, the chlorine level was slowly reduced from 2 isolates were from seven different types of culture specimens: ppm to 0.5 ppm. Analysis of biweekly environmental samples sputum (43) , bronchoalveolar lavage fluid (18), pleural fluid for Legionella has remained negative since this dual chlorinator (6), lung tissue (5), blood (1), fascia (1), and chest wound system was installed, and there have been no additional nosoco-(1). More specimens were acquired via bronchoscopy from mial cases of legionellosis identified.
the transplant recipients than from the nontransplant recipients During the study period (January 1986 to December 1994), (nine vs. six, respectively) because of a more aggressive ap-545 heart, 3,655 liver, 1,799 kidney, and 224 single-or doubleproach in management of transplant patients with lung infillung transplantations were performed. The average yearly incitrates. Nonpulmonary (fascia, blood, and chest wound) isolates dence of legionella infection per 1,000 transplants was as folwere recovered only from transplant patients. We have not lows: 2.07 (95% CI, 0 -6.11), lung transplant population; 1.85 encountered any legionella infections of skin, soft tissue, or (95% CI, 0.38 -3.32), heart transplant population; 0.28 (95% blood in nontransplant patients. CI, 0.03 -0.53), liver transplant population; and 0.24 (95% CI, Of the 40 patients with legionellosis, 29 had L. pneumophila 0 -0.57), kidney transplant population (table 1). The relative or L. micdadei isolated from a sputum culture. For six patients, risk of development of legionellosis for the different organ no sputum samples were submitted for culture. Legionella recipients was compared with that for recipients of liver transplants, which is the most prevalent transplanted organ in our pneumonia was diagnosed by analysis of bronchoalveolar la- 25 (96%) of 26 nontransplant patients developed either renal failure or thoracic complications. Acute renal failure occurred in 54% of nontransplant patients (seven of whom required vage fluid for 4 patients, analysis of pleural fluid for 1 patient, dialysis) and in 57% of transplant patients (two of whom reand culture of a lung tissue specimen obtained at autopsy for quired dialysis). Empyema occurred only in five transplant 1 patient. Sputum samples from four patients were submitted patients (P Å .004), whereas barotrauma occurred only in seven for culture within 2 days of bronchoscopy, but these cultures nontransplant patients (P Å .071). The overall number of pawere negative for Legionella species. From another patient, tients with lung abscess or cavitation, pleural effusion, and culture of a sputum specimen that was obtained 9 days before empyema in the transplant group was 7 (50%), 6 (43%), and bronchoscopy yielded no growth of Legionella species. All 5 (36%), respectively. In the nontransplant group, 19 patients five patients underwent bronchoscopy, and L. pneumophila was (73%) developed pleural effusions, six (23%) developed lung isolated from their bronchoalveolar lavage fluid specimens. abscess or cavitation, and none developed empyema. The most frequent Legionella isolate recovered from both Mortality. In the transplant group, there were six deaths transplant and nontransplant patients was L. pneumophila sero-(43%), five of which were legionella-related. In the nontransgroup 1, previously most commonly isolated from our hospital plant group, 16 patients (62%) died, 14 of whom had legionellawater supply (table 3) . L. pneumophila serogroups 3, 4, 5, and related deaths. To determine which factors were related to an 6 and L. micdadei were infrequently isolated in both groups.
increased mortality rate associated with Legionella species, a One patient was infected simultaneously with both L. pneumultivariate stepwise analysis with use of Cox regression was mophila serogroups 1 and 6.
performed. The following factors were included in the stepwise The DNA probe test for Legionella species was performed on 35 of 67 culture specimens positive for Legionella species that were obtained before or within 24 hours of institution of These symptoms were present at a similar frequency among thus, Legionella species could not be isolated, but direct fluorescent antibody staining and DNA probe testing were positive.
both transplant and nontransplant patients.
/ 9c5c$$de38 11-11-98 17:03:57 cida UC: CID procedure: age, number of days to the diagnosis of legiowho was treated with erythromycin together with ciprofloxacin died. For three patients, the initial antibiotic regimen was nellosis, culture specimen, organ transplantation, presence of concurrent infections, need for intubation, administration of changed because of clinical failure; of these patients, one who survived was initially treated for 5 days with ciprofloxacin and appropriate antibiotics, lung abscess or cavitation formation, and presence of pleural effusions. In the stepwise procedure, then with erythromycin. The other two patients died; one patient was treated with erythromycin and rifampin for 5 days some of the factors were incorporated as time-dependent covariates (i.e., presence of concurrent infections, need for intubaand then with ciprofloxacin, and one patient was treated with erythromycin and trimethoprim-sulfamethoxazole for 3 days tion, administration of appropriate antibiotics, lung abscess or cavitation formation, and presence of pleural effusion). The and then with erythromycin and rifampin. Although most transplant patients were treated with erythromycin with or without factors independently associated with an increased mortality rate included hospital-acquired infection, need for intubation, rifampin, it should be noted that three transplant recipients who survived were treated with ciprofloxacin, ofloxacin, and formation of lung abscess or cavitation, and presence of pleural effusion (table 5) .
ciprofloxacin and rifampin, respectively. Appropriate antibiotic therapy was begun the day before the diagnosis of legionellosis Antibiotic treatment. Most nontransplant patients were treated with erythromycin with or without rifampin. One patient in 10 patients, five of whom died. Appropriate antibiotic ther- / 9c5c$$de38 11-11-98 17:03:57 cida UC: CID apy was begun on the day of the diagnosis of legionellosis in quency of concurrent infections were lower among these patients, as was the overall incidence of complications (table 4) . 15 patients, six of whom died. All seven patients who were not treated with appropriate antibiotics died.
Although statistical significance was not achieved, there was a trend toward less severe disease in the transplant population. The explanation for these differences is not clear. Prophylaxis Discussion with trimethoprim-sulfamethoxazole cannot be implicated since only two of the transplant patients were receiving prophyLegionellosis is a severe pulmonary infection occurring in immunosuppressed and normal hosts. Most reported cases of laxis at the time of admission. It is possible that transplant patients may present to medical attention earlier, a result of a legionellosis in transplant recipients occurred in renal, heart, and bone marrow transplant patients, but only few cases in careful and continuous follow-up. L. micdadei pneumonia, which was originally described at lung and liver transplant recipients have been reported [2 -7, 10, 18 -25] . In this study, approximately one-third of the paour institution in 1979 [29] , tends to occur in severely immunocompromised patients [18, 30] . Of the 40 cases of legionellosis, tients were transplant recipients. The annual incidence of legionella infection was highest among lung transplant recipients, only one was caused by L. micdadei. This case was communityacquired and occurred in a nontransplant patient who received followed by heart, liver, and kidney transplant recipients. Previous studies showed that the incidence of legionella infection corticosteroid therapy for systemic lupus erythematosus. Tacrolimus (formerly called FK-506), a new macrolide used was 7.7% among heart transplant recipients [10] , 23.6% among kidney transplant recipients [18] , and 1.2% among liver transto prevent organ rejection, has been widely studied as a primary immunosuppressive agent at our institution since August 1989. plant recipients [4] . These studies relied on positive serology; therefore, the rates overestimated the incidence of legionellosis.
In comparison with cyclosporin A, it was associated with a lower incidence of bacterial and fungal infections but with a Our case definition was based on positivity of culture or DFA staining in addition to clinical symptoms; thus, our study resimilar incidence of cytomegalovirus infection [31 -34] . Only two of our transplant patients received tacrolimus therapy; the sulted in a lower but more accurate incidence [3, 5] .
The overall mortality rate among nontransplant patients with other 12 patients received immunosuppressive therapy with cyclosporin A. legionellosis has been reported as 14.6% -42.8%, with higher mortality rates (65%) in nosocomial cases [8, 9, 26, 27] . Our Pleural effusion, empyema, and lung abscess or cavitation formation are recognized complications of legionella pneumooverall mortality rate associated with legionellosis was 54%. The mortality rate among patients who acquired legionella innia, the latter of which is most commonly described in severely immunosuppressed patients [8, 35 -37] . In our study, empyema fection nosocomially, however, was 79% compared with 42% among patients with community-acquired cases. A comparison occurred only in transplant recipients, and it may be a result of reduced ability to locally contain infection with Legionella of the relative risk of nosocomial legionellosis between transplant and nontransplant patients would be of interest, but we species that is induced by immunosuppressive agents with activity against T cells. Renal insufficiency or failure is a recogwere unable to perform this evaluation because our data were limited to patients with legionellosis only and all other hospitalnized complication of legionellosis and portends a worse prognosis [38] . The etiologies of renal failure include sepsis, ized patients with pneumonia seen during the same period were not included in the study. Patients receiving corticosteroid therhypotension, rhabdomyolysis, administration of nephrotoxic agents, and acute tubulointerstitial nephritis due to L. pneuapy are at high risk for developing legionellosis and are more likely to die than are otherwise healthy hosts [2, 28] . The mophila. The mortality rate among our patients who developed renal insufficiency or failure was 68%, similar to findings of mortality rate among the nontransplant patients with underlying illnesses was higher than that among those without underlying other investigators [39] . Concomitant infections with legionella infection are reported to occur at a frequency of 5% -10% [2, illnesses, among whom the mortality rate was 50%. Specifically, the mortality rates among patients receiving corticoste-11, 40]. The higher incidence of bacteremia in the nontransplant group along with the higher incidence of invasive fungal infecroid therapy, patients with diabetes mellitus, patients with cirrhosis, and patients with hematologic or oncological tions in the transplant group suggests that the transplant patients may have received more empirical antibiotic therapy. malignancy were 56%, 100%, 80% and 75%, respectively; both of the patients with AIDS survived.
The sensitivity of DFA staining has been reported as 20% -70% [9, 41 -43] . When compared with positive culture, the Mortality rates associated with legionellosis in the transplant population are not well documented [1, 4, 5, 7, 20] . In one sensitivity of DFA staining was 88%, and that of DNA probe testing was 63% (which is comparable with sensitivities of study, the mortality rate among heart transplant patients with legionnaires' disease was 17% compared with 4.7% among 31% -67% previously reported by Finkelstein et al. [42] ). We previously reported equivalent sensitivities for the two methods nontransplant surgical cardiac patients [3] . Surprisingly, in our study, solid organ transplant recipients appeared to have relafor patients who had cultures positive for Legionella species (DNA probe testing, 81.8%; DFA staining, 72.7%) [44] . Most tively less severe illness than did other patients. The legionellarelated mortality rate, the incidence of intubation, and the freof the previous studies used serology as a diagnostic criterion / 9c5c$$de38 11-11-98 17:03:57 cida UC: CID
